MX26142A - Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno. - Google Patents

Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.

Info

Publication number
MX26142A
MX26142A MX2614291A MX2614291A MX26142A MX 26142 A MX26142 A MX 26142A MX 2614291 A MX2614291 A MX 2614291A MX 2614291 A MX2614291 A MX 2614291A MX 26142 A MX26142 A MX 26142A
Authority
MX
Mexico
Prior art keywords
leucotrene
derivatives
benzoic acid
diseases related
treat diseases
Prior art date
Application number
MX2614291A
Other languages
English (en)
Spanish (es)
Inventor
Robert A Daines
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX26142A publication Critical patent/MX26142A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2614291A 1990-06-07 1991-06-06 Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno. MX26142A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
MX26142A true MX26142A (es) 1994-02-28

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2614291A MX26142A (es) 1990-06-07 1991-06-06 Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.

Country Status (16)

Country Link
EP (1) EP0532550A1 (ja)
JP (1) JPH05507475A (ja)
KR (1) KR930700445A (ja)
CN (1) CN1058016A (ja)
AU (1) AU7901791A (ja)
CA (1) CA2083958A1 (ja)
FI (1) FI925544A (ja)
HU (1) HUT64748A (ja)
IE (2) IE911912A1 (ja)
IL (1) IL98388A0 (ja)
MA (1) MA22196A1 (ja)
MX (1) MX26142A (ja)
PL (1) PL290586A1 (ja)
PT (1) PT97912A (ja)
WO (1) WO1991018880A1 (ja)
ZA (1) ZA914323B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022285A1 (en) * 1992-05-01 1993-11-11 Smithkline Beecham Corporation Leukotriene antagonists
WO1995015950A1 (en) * 1993-12-08 1995-06-15 Smithkline Beecham Corporation Compounds
MA22926A1 (fr) * 1992-06-30 1994-04-01 Smithkline Beecham Corp Procede pour la preparation de nouveaux composes.
JPH08505148A (ja) * 1992-12-23 1996-06-04 スミスクライン・ビーチャム・コーポレイション ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物
WO1995028386A1 (en) * 1994-04-13 1995-10-26 F. Hoffmann-La Roche Ag Substituted pyridine leukotriene b4 antagonists
US7297357B2 (en) * 2001-03-27 2007-11-20 Meiji Seika Kaisha, Ltd. Process for producing puffed snack and production apparatus therefor
EP3192872A1 (en) 2003-08-26 2017-07-19 The Regents of the University of Colorado, a body corporate Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
IE911912A1 (en) 1991-12-18
CA2083958A1 (en) 1991-12-08
HUT64748A (en) 1994-02-28
JPH05507475A (ja) 1993-10-28
KR930700445A (ko) 1993-03-15
PL290586A1 (en) 1992-04-06
AU7901791A (en) 1991-12-31
MA22196A1 (fr) 1992-04-01
EP0532550A1 (en) 1993-03-24
IL98388A0 (en) 1992-07-15
ZA914323B (en) 1992-06-24
HU9203866D0 (en) 1993-03-29
FI925544A0 (fi) 1992-12-07
CN1058016A (zh) 1992-01-22
PT97912A (pt) 1992-03-31
IE911913A1 (en) 1991-12-18
WO1991018880A1 (en) 1991-12-12
FI925544A (fi) 1992-12-07

Similar Documents

Publication Publication Date Title
AR240949A1 (es) Procedimiento para preparar derivados de acido n-(aminoalcanoil)-aza-biciclocarboxilico
ES538958A0 (es) Procedimiento para la obtencion de derivados del acido benzoico
MX9200216A (es) Procedimiento para la preparacion de anhidrido de acido malonico.
EE9500059A (et) Asendatud 4-fenüül-6-aminonikotiinhappe derivaatide kasutamine ravimitena
IT1150198B (it) Derivato di acido chinolincarbossilico
ES533495A0 (es) Procedimiento para la preparacion de derivados del acido oxamidico
MX9205435A (es) Derivados del acido imidazolil-propenico substituidos y procedimiento para su fabricacion.
MX7101E (es) Procedimiento para la preparacion de derivados de acido quinolin-carboxilico
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
AR230056A1 (es) Procedimiento para la preparacion de derivados del acido 3-ridilmetilo 3-piridilmetilo 3-inidazolilmetil indolil-acrilico
MX26142A (es) Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno.
NO844462L (no) Bruk av ultraren hyaluronsyre for aa forbedre dyreleddfunksjoner
MX9205436A (es) Derivados del acido imidazolil-propenico y procedimiento para su fabricacion
ES535000A0 (es) Procedimiento para la preparacion de derivados de acido piridacinilcarboxilico
ES538029A0 (es) Procedimiento para la preparacion de derivados del acido indolacetico
ES546419A0 (es) Procedimiento para la preparacion de derivados de acido 4- (isoxazolil)-tiazol-2-oxamico
ES508647A0 (es) Procedimiento de preparar derivados de acido carboxilico quetienen actividad antibacteriana.
BR9202293A (pt) Processo para preparacao de acido 5-hidroxipirazinocarboxilico
NO904184D0 (no) Anvendelse av alkylfosforsyreforbindelser for bekjempelseav psoriasis-sykdommer.
ES2014390A4 (es) Proceso para la fabricacion de mezclas de eteres acido carboxilicos
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
MX9204109A (es) Derivados de acido 2-(imidazol-1-il)-2-bencil-etiliden-aminoxialcanoico y proceso para su preparacion.
ES491601A0 (es) Procedimiento para la preparacion de derivados de acido n-acil-amino
IT1162323B (it) Procedimento per la produzione di e steri di acido benzoico
ES502848A0 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico